azacitidine has been researched along with Leukemia L5178 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadman, E; Grant, S | 1 |
| Nakamura, N; Okada, S | 1 |
| Caspary, WJ; Hines, KC; Spencer, DL | 1 |
| Caspary, WJ; Gibis, P; Körber, C; Spencer, DL; Stopper, H | 1 |
| Eckert, I; Schulz, WA; Stopper, H; Wagener, P | 1 |
| Amacher, DE; Turner, GN | 1 |
| Applegate, ML; Hozier, JC; Moore, MM | 1 |
| Brown, AG; Caspary, WJ; Cattanach, P; Daston, DS; McGregor, DB; Riach, C; Shepherd, W | 1 |
8 other study(ies) available for azacitidine and Leukemia L5178
| Article | Year |
|---|---|
Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
Topics: 3-Deazauridine; Animals; Azacitidine; Biological Transport; Clone Cells; DNA, Neoplasm; Humans; Leukemia L5178; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Neoplasm Proteins; Ribonucleotides; RNA, Neoplasm; Uridine | 1980 |
Mutations resistant to bromodeoxyuridine in mouse lymphoma cells selected by repeated exposure to EMS. Characteristics of phenotypic instability and reversion to HAT resistance by 5-azacytidine.
Topics: Animals; Azacitidine; Bromodeoxyuridine; DNA Replication; Drug Resistance; Ethyl Methanesulfonate; Hypoxanthine Phosphoribosyltransferase; Leukemia L5178; Leukemia, Experimental; Mice; Mutation; Phenotype; Thymidine Kinase | 1983 |
An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells.
Topics: Animals; Azacitidine; Cell Division; Cell Separation; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance; Leukemia L5178; Mice; Mutagenesis, Site-Directed; Mutagenicity Tests; Mutagens; Phenotype; Reproducibility of Results; Thymidine Kinase; Trifluridine; Tumor Cells, Cultured | 1994 |
Micronuclei induced by modulators of methylation: analogs of 5-azacytidine.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Deoxycytidine; Leukemia L5178; Methylation; Mice; Mice, Inbred C3H; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutation | 1995 |
Formation of micronuclei and inhibition of topoisomerase II in the comet assay in mammalian cells with altered DNA methylation.
Topics: Amsacrine; Animals; Azacitidine; Carcinoma, Embryonal; Cell Differentiation; DNA Methylation; DNA, Neoplasm; Enzyme Inhibitors; Ethyl Methanesulfonate; In Situ Hybridization; Kinetochores; Leukemia L5178; Mammals; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1997 |
The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cell.
Topics: Animals; Aphidicolin; Azacitidine; Cell Line; Cytidine; Diterpenes; Drug Resistance; Leukemia L5178; Leukemia, Experimental; Mice; Mutagens; Thymidine; Trifluridine | 1987 |
Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
Topics: Animals; Azacitidine; Drug Resistance; Leukemia L5178; Leukemia, Experimental; Mice; Mutation; Thymidine; Thymidine Kinase; Translocation, Genetic; Trifluridine; Tumor Cells, Cultured | 1988 |
TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine.
Topics: Animals; Azacitidine; Cell Differentiation; Dose-Response Relationship, Drug; Drug Resistance; Hypoxanthine Phosphoribosyltransferase; Leukemia L5178; Mice; Mutation; Thioguanine; Thymidine Kinase; Trifluridine; Tumor Cells, Cultured | 1989 |